Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Expensive Performer
1075.8500
10.10
(
0.95
%)
NSE
Mar 19, 2025
10:14 AM
49.48% Gain from 52W Low
Volume:
17,033
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
29 Apr 2024
1075.85
0.95%
Glenmark Life Science
Buy:
Alivus Life Sciences Ltd.
by
ICICI Direct
Target: 1040 | Target met
ICICI Direct
Alivus Life Sciences Ltd.'s price crossed above 200Day SMA today
More from Alivus Life Sciences Ltd.
Recommended
Market opens higher, Bajaj Auto reappoints Rajivnayan Bajaj as MD & CEO from April 1
Trendlyne Marketwatch |
19 Mar 2025, 10:03AM
Five stocks to buy from analysts this week - March 18, 2025
The Baseline |
18 Mar 2025, 05:17PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021